DNA repair in Etoposide-induced DNA damage in lymphocytes of breast cancer patients and healthy women

International Journal of Clinical and Experimental Medicine

Volumn 2, Issue 3, 2009, Pages 280-288

  Teixeira, Ana Claudia ^a   Dos Santos, Raquel Alves ^a   Poersch, Aline ^a   Carrara, Helio Humberto Angotti ^a   De Andrade, Jurandyr Moreira ^a   Takahashi, Catarina Satie ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Breast cancer; Comet assay; Dna repair; Etoposide; Micronucleus test

Indexed keywords

ETOPOSIDE; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BREAST CARCINOMA; CLINICAL ARTICLE; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA DETERMINATION; DNA REPAIR; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE; MICRONUCLEUS TEST;

EID: 74549121906     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Olopade OI and Pichert G. Cancer genetics in oncology practice. Ann Oncol 2001; 12: 895-908.
2. Wooster R and Weber BL. Breast and ovarian cancer. N Engl J Med 2003; 348: 2339-47.
3. Risch A, Wikman H, Thiel S, Schmezer P, Edler L, Drings P, Dienemann H, Kayser K, Schulz V, Spiegelhalder B and Bartsch H. Glutathione-S-transferase M1, M3, T1 and P1 polymorphisms and susceptibility to non-small-cell lung cancer subtypes and hamartomas. Pharmacogenetics 2001; 11: 757-64.
4. Chacko P, Rajan B, Joseph T, Mathew BS and Pillai MR. Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancer. Breast Cancer Res Treat 2005; 89: 15-21.
5. Smith TR, Miller MS, Lohman K, Lange EM, Case LD, Mohrenweiser HW and Hu JJ. Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer. Cancer Lett 2003; 190: 183-90.
6. Synowiec E, Stefanska J, Morawiec Z, Blasiak J and Wozniack K. Association between DNA damage repair genes variability and clinical characteristics in breast cancer patients. Mutat Res 2008; 648: 65-72.
7. Belani CP, Doyle LA and Aisner J. 1994. Etoposide: current status and future perspectives in the management of malignant neoplasms. Cancer Chemother Pharmacol 1994; 34 (Suppl.): 118-26.
8. Hande KR. Clinical applications of anticancer drugs targeted to topoisomerase II. Biochim Biophys Acta 1998; 1400: 173-84.
9. Fenech M. The advantages and disadvantages of the cytokinesis-block micronucleus method. Mutat Res 1997; 392: 11-18.
10. Ribas G, Frenzilli G, Barale R and Marcos R. Herbicide-induced DNA damage in human lymphocytes evaluated by the single-cell electrophoresis (SCGE) assay. Mutat Res 1995; 344: 41-54.
11. Ross GM, McMillan TJ, Wilcos P and Collins AR. 1995. The single cell microgel electrophoresis assay (comet assay): technical aspects and applications - Report on the 5th LH Gray Trust Workshop, Institute of Cancer Research in 1994. Mutat Res 1995; 337: 57-60.
12. Tice RR: The single cell gel/ Comet assay: a microgel eletrophoretic technique for the detection of DNA damage and repair in individual cells. In: Phillips DH and Venitt S (Eds.), Environmental Mutagenesis. Bios Scientific Publishers Ltd. Oxford, 1995, pp. 315-39.
13. Klaude M, Eriksson S, Nygren J and Ahnström G. The comet assay: Mechanisms and technical considerations. Mutat Res 1996; 363: 89-96
14. Anderson D and Plewa MJ. The international comet assay workshop. Mutagenesis 1998; 13: 67-73.
15. Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu JC and Sasaki YF. The single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Mutat Res 2000; 35: 206-21.
16. Frieauff W, Hartmann A and Suter W. Automatic analysis of slides processed in the comet assay. Mutagenesis 2001; 16: 133-7.
17. Fenech M and Morley AA. Measurement of micronuclei in lymphocytes. Mutat Res 1985; 147: 29-36.
18. Fenech M. The cytokinesis-block micronucleus technique and its application to genotoxicity studies in human populations. Environ Health Perspect 1993; 101: 101-7.
19. Titenko-Holland N, Windham G, Kolachana P, Reinisch F, Parvatham S, Osorio AM and Smith MT. Genotoxicity of malathion in human lymphocytes assessed using the micronucleus assay in vitro and in vivo: A study of malathion-exposed workers. Mutat Res 1997; 388: 85-95.
20. Eastmond DA and Tucker JD. Identification of aneuploidy-inducing agents using cytokinesis-blocked human lymphocytes and an antikinetochore antibody. Environ Mol Mutagen 1989; 13: 34-43.
21. Singh NP, McCoy MT, Tice RR and Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 1988; 175: 184-91.
22. Roberts SA, Spreadborough AR, Bulman B, Barber JB, Evans DG and Scott D. Heritability of cellular radiosensitivity: a marker of low-penetrance predisposition genes in breast cancer? Am J Hum Genet 1999; 65: 784-94.
23. Khanna KK and Jackson SP. DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 2001; 27: 247-54.
24. Bau DT, Mau YC, Ding SL, Ei P, Sheen W and Sheen CY. DNA double-strand break repair capacity and risk of breast cancer. Carcinogenesis 2007; 28: 1726-30.
25. Lord CJ, Garret MD and Ashworth A. Targeting the double-strand DNA break repair pathway as a therapeutic strategy. Clin Cancer Res 2006; 12: 4463-68.
26. Lebailly P, Vigreux C, Godard T, Sichel F, Bar E, LeTalaër JY, Henry-Amar M and Gauduchon P. Assessment of DNA damage in vitro by Etoposide and two fungicides (carbendazim and chlorothalonil) in humam lymphocytes with the comet assay. Mutat Res 1997; 375: 205-17.
27. Schabath MB, Spitz MR, Grossman HB, Zhang K, Dinney CP, Zheng PJ and Wu X. Genetic instability in bladder cancer assessed by the comet assay. J Natl Cancer Inst 2003; 95: 540-7.
28. Hamurcu Z, Dönmez-Altuntas H and Patiroglu T. Basal level of micronucleus frequency in stimulated lymphocytes of untreated patients with leukemia. Cancer Genet Cytogenet 2008; 180: 140-4.
29. Lou J, He J, Zheng LW, Jin L, Chen Z, Chen S, Lin Y and Xu S. 2007. Investigating the genetic instability in the peripheral lymphocytes of 36 untreated lung cancer patients with comet assay and micronucleus assay. Mutat Res 2007; 617: 104-10.
30. Varga D, Hoegel J, Maier C, Jainta S, Hoehne M, Patino-Garcia B, Michel I, Schwarz-Boeger U, Kiechle M, Kreienberg R and Vogel W. On the difference of micronucleus frequencies in peripheral blood lymphocytes between breast cancer patients and controls. Mutagenesis 2006; 21: 313-20.
31. Bromberg KD, Burgin AB and Osheroff N. A two-drug model for action against human topoisomerase IIá. J Biol Chem 2002; 278: 7406-7412.
32. Vukicevic V, Kampfinger K and Stopper H. Influence of altered apoptosis in human lymphoblastoid cell lines on micronucleus frequency. Toxicol Lett 2004; 147: 187-95.
33. Turner SD, Wijnhoven SWP, Tinwell H, Lashford LS, Rafferty JA, Ashby J, Vrieling H and Fairbairn LJ. Assays to predict the genotoxicity of the chromosomal mutagen Etoposide-focusing on the best assay. Mutat Res 2001; 493: 139-47.
34. Wozniak AJ and Ross WE. DNA damage as a basis for 4′- demethylepipodophyllotoxin-9-(4,6-O-ethylidene-beta-D-glucopyranoside) (Etoposide) cytotoxicity. Cancer Res 1983; 43: 120-4.
35. van Maanen JM, Retèl J, de Vries J and Pinedo HM. Mechanism of action of antitumor drug Etoposide: a review. J Natl Cancer Inst 1988; 80: 1526-33.
36. Gontijo AMMC and Tice R: Comet assay for detection of DNA damage and repair in individual cells. In: Mutagênese ambiental (Ribeiro LR, Salvadori DMF and Marques EK, eds.). ULBRA Inc. Canoas, RS, Brazil, 2003, pp. 247-75.
37. Azevedo L, Gomes JC, Strigheta PC, Gontijo AMMC, Padovani CR, Ribeiro LR and Salvadori DMF. Black bean (Phaseolus vulgaris L.) as a protective agent against DNA damage in mice. Food Chem Toxicol 2003; 41: 1671-76.
38. Vaghef H, Nygren P, Edling C, Bergh J and Hellman B. Alkaline single-cell gel electrophoresis and human biomonitoring for genotoxicity: a pilot study on breast cancer patients undergoing chemotherapy including cyclophosphamide. Mutat Res 1997; 395: 127-38.
39. Jaloszynski P, Kujawski M, Czub-Swierczek M, Markowska J and Szyfter K. Bleomycin-induced DNA damage and its removal in lymphocytes of breast cancer patients studied by comet assay. Mutat Res 1997; 385: 223-33.